PIL - Co-codamol 15/500mg Film-coated Tablets: Change history
View Patient Information Leaflet (PIL - Co-codamol 15/500mg Film-coated Tablets)
Last updated on this site: 03 May 2023
Variation description:
Update to SPC section 4.4 and PIL in line with the recommendations following MHRA review of myasthenia gravis (SA 19083871).
Update to PIL in line with the recommendations following MHRA review of CNS depressants (SA 18643283).
Additional update to SPC section 4.2 for 15/500mg strength only to correct strength from ‘500mg/15mg’ to ‘15mg/500mg’ in the renal insufficiency table.
Amends to the PIL in line with the latest QRD template (Version 10.3), and correction of ‘cinacelet’ to ‘cinacalcet’.
PIL sections updated- Heading, Introduction, 2, 3, 4 and 6.
Last updated on this site: 03 May 2023
Variation description:
Update to SPC section 4.4 and PIL in line with the recommendations following MHRA review of myasthenia gravis (SA 19083871).
Update to PIL in line with the recommendations following MHRA review of CNS depressants (SA 18643283).
Additional update to SPC section 4.2 for 15/500mg strength only to correct strength from ‘500mg/15mg’ to ‘15mg/500mg’ in the renal insufficiency table.
Amends to the PIL in line with the latest QRD template (Version 10.3), and correction of ‘cinacelet’ to ‘cinacalcet’.
PIL sections updated- Heading, Introduction, 2, 3, 4 and 6.
-
Changes: (Updated: 03 May 2023)
Variation description:
Update to SPC section 4.4 and PIL in line with the recommendations following MHRA review of myasthenia gravis (SA 19083871).
Update to PIL in line with the recommendations following MHRA review of CNS depressants (SA 18643283).
Additional update to SPC section 4.2 for 15/500mg strength only to correct strength from ‘500mg/15mg’ to ‘15mg/500mg’ in the renal insufficiency table.
Amends to the PIL in line with the latest QRD template (Version 10.3), and correction of ‘cinacelet’ to ‘cinacalcet’.
PIL sections updated- Heading, Introduction, 2, 3, 4 and 6.
-
Changes: (Updated: 22 Sep 2022)
initial upload